Marc Voigt, CEO of Immutep will participate in the upcoming virtual event and will deliver a presentation.

Speaking time of Marc Voigt: 12:30 pm AEDT on Friday, 17 February 2023

Link to the Presentation

Marc Voigt, CEO and Deanne Miller, COO will be attending and hosting meetings at the 41st Annual J.P. Morgan Healthcare Conference taking place January 9-12, 2023 at the Westin St. Francis in San Francisco, CA. 

Marc Voigt, CEO of Immutep will participate in the event virtually and will deliver a corporate presentation.

Speaking time of Marc Voigt: 11:20 AM ET on Wednesday, 7 December 2022

Link to the webcast

Immutep Annual General Meeting 2022 will be taking place at Offices of Piper Alderman, Governor Macquarie Tower, 1 Farrer Place, Sydney, NSW on Wednesday, 23 November 2022, 11.00 am (AEDT)

Notice of Meeting

Marc Voigt, CEO of Immutep will participate in the upcoming in-person conference

Speaking time of Marc Voigt: 1:30pm - 2.00pm (UTC) on Thursday, 17 November 2022

A replay of the webcast is available here

For questions, please email londonhealthcareconf@jefferies.com 

The company will participate in the upcoming in-person conference.

Venue: Boston, MA

https://ascopost.com/videos/sitc-2022/wade-iams-on-nsclc-combining-an-antigen-presenting-cell-activator-with-pembrolizumab/

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming virtual conference and will deliver a presentation.

Speaking time of Marc Voigt: 10:00am - 10:30am (AEDT) on Wednesday, 9 November 2022 

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming conference to present a corporate overview

Link to Webcast

Marc Voigt, CEO and Deanne Miller, COO will participate in the in-person conference 

Immutep will participate in the 2nd Non-Small Cell Lung Cancer Drug Development Summit

Frédéric Triebel, CSO & CMO of Immutep speaks on the subject:

A Soluble LAG-3 Protein (Eftilagimod Alpha) with an Anti-PD-1 Antibody (Pembrolizumab): Results of a Phase II Study in NSCLC

Speaking time of Frederic Triebel: 12.00 EST, Thursday 22nd September 2022

Click here for the Presentation

Click here for the Event Guide

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the virtual Investor' Forum

Marc Voigt, CEO of Immutep will participate in the conference virtually and Deanne Miller, COO will participate in person.

Speaking time of Marc Voigt: 15:50 pm – 16:20 pm AEST on Tuesday, 6 September 2022

Immutep will attend to the 2022 World Conference on Lung Cancer.

Marc Voigt, CEO of Immutep will participate in the upcoming in-person conference and will be available for one to one investor meetings in New York City on June 8-10, 2022.

Speaking time of Marc Voigt: 8:30 AM ET on 10 June, 2022

Venue: McCormick Place, Chicago, IL, USA

Immutep will participate in this year`s event.

Immutep will attend to the ESMO Breast Cancer Congress 2022.

The conference will be a virtual format and involve an informal panel discussion followed by Q&A from the audience.

To join the live event, please contact your Goldman Sach’s representative.

Speaking time of Marc Voigt/ CEO: 3:45pm AEST on 29th April

Marc Voigt, CEO of Immutep will participate in the upcoming digital event.

Immutep is presenting new data at the European Lung Cancer Congress 2022.

CEO Marc Voigt will participate in a fireside chat plus corporate presentation.
Fireside chat time & date: 11:00 am Eastern Daylight Time (EDT) on Monday 28 March 2022.